Personal Home Page

http://bio.utsa.edu/ntfaculty/aliev.html

Articles in Scholarly Journals [Incomplete List]

1. Nucleic acid oxidation in Alzheimer disease
   Free Radical Biology and Medicine, vol. 44, no. 8, pp. 1493–1505, 2008
2. Vascular oxidative stress in Alzheimer disease
   Journal of the Neurological Sciences, vol. 257, no. 1-2, pp. 240–246, 2007
3. Autophagocytosis of Mitochondria Is Prominent in Alzheimer Disease
   Journal of Neuropathology and Experimental Neurology, vol. 66, no. 6, pp. 525–532, 2007
4. Integrated treatment approach improves cognitive function in demented and clinically depressed patients
   American Journal of Alzheimer's Disease and Other Dementias, vol. 20, no. 1, pp. 21–26, 2005
5. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes
   Journal of Cerebral Blood Flow & Metabolism, vol. 25, no. 6, Article ID 9600057, 9 pages, 2005
6. Biphasic expression of lipin suggests dual roles in adipocyte development
   Drug News & Perspectives, vol. 18, no. 1, p. 13, 2005
7. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease
   Journal of the Neurological Sciences, vol. 229-230, pp. 285–292, 2005
8. Oxidative Stress: The Old Enemy in Alzheimer's Disease Pathophysiology
   Current Alzheimer Research, vol. 2, no. 4, pp. 403–408, 2005
9. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
   Free Radical Biology and Medicine, vol. 38, no. 6, pp. 746–754, 2005
10. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease
    Mitochondrion, vol. 4, no. 5-6, pp. 649–663, 2004
11. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease
    Journal of Neural Transmission, vol. 112, no. 7, pp. 921–932, 2004
12. Drug Therapy in Alzheimer's Disease
    New England Journal of Medicine, vol. 351, no. 18, pp. 1911–1913, 2004
13. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?
    Neurological Research, vol. 26, no. 5, pp. 547–553, 2004
14. Mitochondrial failures in Alzheimer's disease
    American Journal of Alzheimer's Disease and Other Dementias, vol. 19, no. 6, pp. 345–352, 2004
15. Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease
    Journal of Biomedicine and Biotechnology, vol. 2003, no. 3, pp. 162–163, 2003
16. Neurochemical Research, vol. 28, no. 10, pp. 1549–1552, 2003
17. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice
    Neurological Research, vol. 25, no. 6, pp. 665–674, 2003
18. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?
    Free Radical Biology and Medicine, vol. 33, no. 11, pp. 1475–1479, 2002
19. Role of mitochondrial dysfunction in Alzheimer's disease
    Journal of Neuroscience Research, vol. 70, no. 3, pp. 357–360, 2002
20. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease
    Journal of Neurochemistry, vol. 76, no. 2, pp. 435–441, 2001
21. Atherosclerotic Lesions Are Associated with Increased Immunoreactivity for Inducible Nitric Oxide Synthase and Endothelin-1 in Thoracic Aortic Intimal Cells of Hyperlipidemic Watanabe Rabbits
    Experimental and Molecular Pathology, vol. 71, no. 1, pp. 40–54, 2001
22. Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of Donryu rats on a cholesterol-enriched diet
    The Anatomical Record, vol. 260, no. 1, pp. 16–25, 2000
23. Oxidative damage in Alzheimer's disease: the metabolic dimension
    International Journal of Developmental Neuroscience, vol. 18, no. 4-5, pp. 417–421, 2000
24. Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome
    Annals of the New York Academy of Sciences, vol. 893, no. 1 OXIDATIVE/ENE, pp. 362–364, 1999
25. Effect of cholesterol-supplemented diet in heritable hyperlipidemic Yoshida rats: functional and morphological characterization of thoracic aorta
    Atherosclerosis, vol. 106, no. 1, pp. 51–63, 1994
26. Endothelium as a therapeutical target in peripheral occlusive arterial diseases: consideration for pharmacological interventions
    Pharmacological Research, vol. 29, no. 4, pp. 293–311, 1994
27. Evidence for the presence of early vascular lesions in newborn Watanabe heritable hyperlipidemic (WHHL) rabbits
    Atherosclerosis, vol. 101, no. 1, pp. 17–24, 1993
28. Changes in Vessel Ultrastructure during Ischemia and Reperfusion of Rabbit Hindlimb: Implications for Therapeutic Intervention
    Microvascular Research, vol. 46, no. 1, pp. 65–76, 1993